NCT00226278View on ClinicalTrials.gov

Safety Study of ORG 34517 for Major Depression With Psychotic Features

PHASE2CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

September 30, 2004

Primary Completion Date

November 30, 2005

Study Completion Date

November 30, 2005

Conditions
Major Depressive DisorderPsychotic Disorders
Interventions
DRUG

ORG 34517

Trial Locations (1)

10021

Weill Cornell Medical College/New York Presbyterian Hospital, New York

All Listed Sponsors
lead

Weill Medical College of Cornell University

OTHER

NCT00226278 - Safety Study of ORG 34517 for Major Depression With Psychotic Features | Biotech Hunter | Biotech Hunter